Classification of inflammatory bowel disease: The old and the new

Current Opinion in Gastroenterology

Volumn 28, Issue 4, 2012, Pages 321-326

  Vermeire, Severine ^a   Van Assche, Gert ^a   Rutgeerts, Paul ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

molecular re classification; Montreal classification; Paris classification; predictors disabling disease

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; ENEMA; INTERLEUKIN 23; INTERLEUKIN 7; SACCHAROMYCES CEREVISIAE PROTEIN;

COLONOSCOPY; COLORECTAL CANCER; CONSENSUS; CROHN DISEASE; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; GROWTH DISORDER; HUMAN; NONHUMAN; PERIANAL MYCOSIS; PRIMARY SCLEROSING CHOLANGITIS; PSEUDOMONAS FLUORESCENS; REVIEW; ULCERATIVE COLITIS;

BIOLOGICAL MARKERS; CROHN DISEASE; DISABILITY EVALUATION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFLAMMATORY BOWEL DISEASES; PROGNOSIS;

EID: 84862294952     PISSN: 02671379     EISSN: 15317056     Source Type: Journal    
DOI: 10.1097/MOG.0b013e328354be1e     Document Type: Review

References (26)

1. Farmer RG, Hawk WA, Turnbull RB Jr. Clinical patterns in crohn's disease: A statistical study of 615 cases. Gastroenterology 1975; 68:627-635.
2. Greenstein AJ, Lachman P, Sachar DB, et al. Perforating and nonperforating indications for repeated operations in crohn's disease: Avidence for two clinical forms. Gut 1988; 29:588-592.
3. Sachar DB, Andrews HA, Farmer RG, et al. Proposed classification of patient subgroups in crohn's disease. Gastroenterol Int 1992; 5:141-154.
4. Gasche C, Scholmerich J, Brynskov J, et al. A simple classification of crohn's disease: Report of the Working Party for the World Congresses of Gastroenterology, Vienna, 1998. Inflamm Bowel Dis 2000; 6:8-15.
5. Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005; 19 (Suppl. A):5-36.
6. Levine A, Griffiths A, Markowitz J, et al. Pediatric modification of the Montreal classification for inflammatory bowel disease: The Paris classification. Inflamm Bowel Dis 2011; 17:1314-1321.
7. Cosnes J, Cattan S, Blain A, et al. Long-term evolution of disease behavior of crohn's disease. Inflamm Bowel Dis 2002; 8:244-250.
8. Louis E, Collard A, Oger AF, et al. Behaviour of crohn's disease according to the Vienna classification: Changing pattern over the course of the disease. Gut 2001; 49:777-782.
9. Beaugerie L, Seksik P, Nion-Larmurier I, et al. Predictors of crohn's disease. Gastroenterology 2006; 130:650-656.
10. Loly C, Belaiche J, Louis E. Predictors of severe crohn's disease. Scand J Gastroenterol 2008; 43:948-954.
11. Tarrant KM, Barclay ML, Frampton CM, Gearry RB. Perianal disease predicts changes in crohn's disease phenotype-results of a population-based study of inflammatory bowel disease phenotype. Am J Gastroenterol 2008; 103: 3082-3093.
12. Thia KT, Sandborn WJ, Harmsen WS, et al. Risk factors associated with progression to intestinal complications of crohn's disease in a populationbased cohort. Gastroenterology 2010; 139:1147-1155.
13. Allez M, Lemann M, Bonnet J, et al. Long term outcome of patients with active crohn's disease exhibiting extensive and deep ulcerations at colonoscopy. Am J Gastroenterol 2002; 97:947-953.
14. Mow WS, Vasiliauskas EA, Lin YC, et al. Association of antibody responses to microbial antigens and complications of small bowel crohn's disease. Gastroenterology 2004; 126:414-424.
15. Arnott ID, Landers CJ, Nimmo EJ, et al. Sero-reactivity to microbial components in crohn's disease is associated with disease severity and progression, but not NOD2/CARD15 genotype. Am J Gastroenterol 2004; 99:2376-2384.
16. Targan SR, Landers CJ, Yang H, et al. Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated crohn's disease. Gastroenterology 2005; 128:2020-2028.
17. Ferrante M, Henckaerts L, Joossens M, et al. New serological markers in inflammatory bowel disease are associated with complicated disease behaviour. Gut 2007; 56:1394-1403.
18. Dubinsky MC, Lin YC, Dutridge D, et al. Western Regional Pediatric IBD Research Alliance. Serum immune responses predict rapid disease progression among children with crohn's disease: Immune responses predict disease progression. Am J Gastroenterol 2006; 101:360-367.
19. Abreu MT, Taylor KD, Lin YC, et al. Mutations in NOD2 are associated with fibrostenosing disease in patients with crohn's disease. Gastroenterology 2002; 123:679-688.
20. Ahmad T, Armuzzi A, BunceM, et al. The molecular classification of the clinical manifestations of crohn's disease. Gastroenterology 2002; 122:854-866.
21. Economou M, Trikalinos TA, Loizou KT, et al. Differential effects of NOD2 variants on crohn's disease risk and phenotype in diverse populations: A metaanalysis. Am J Gastroenterol 2004; 99:2393-2404.
22. Weersma RK, Stokkers PC, Van Bodegraven AA, et al. Dutch Initiative on Crohn and Colitis (ICC). Molecular prediction of disease risk and severity in a large Dutch crohn's disease cohort. Gut 2009; 58:388-395.
23. Henckaerts L, Van Steen K, Verstreken I, et al. Genetic risk profiling and prediction of disease course in crohn's disease patients. Clin Gastroenterol Hepatol 2009; 7:972-980.
24. Cleynen I, Mahachie John JM, Henckaerts L, et al. Molecular reclassification of crohn's disease by cluster analysis of genetic variants. PLoS One 2010; 5:e12952.
25. Lee JC, Lyons PA, McKinney EF, et al. Gene expression profiling of CD8+ T cells predicts prognosis in patients with Crohn disease and ulcerative colitis. J Clin Invest 2011; 121:4170-4179.
26. McKinney EF, Lyons PA, Carr EJ, et al. A CD8+ T cell transcription signature predicts prognosis in autoimmune disease. Nat Med 2010; 16:586-591.